Fresenius Medical Care AG & Co. KGaA

FMS · NYSE
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$275$272$190$67
Dep. & Amort.$382$375$394$392
Deferred Tax$0-$23-$30$0
Stock-Based Comp.$0$0$0$38
Change in WC-$278$282-$385$5
Other Non-Cash$363-$132-$6$330
Operating Cash Flow$742$775$163$832
Investing Activities
PP&E Inv.-$192-$154-$146-$241
Net Acquisitions-$3-$8$13$18
Inv. Purchases$0$0-$12$0
Inv. Sales/Matur.$0$12$33$0
Other Inv. Act.$141$8$3$103
Investing Cash Flow-$54-$142-$108-$119
Financing Activities
Debt Repay.-$669$547-$79-$737
Stock Issued$0$0$0$0
Stock Repurch.-$151$0$0$0
Dividends Paid$0-$423$0$0
Other Fin. Act.-$315-$45-$60-$228
Financing Cash Flow-$1,135$79-$139-$965
Forex Effect-$16-$71-$22$51
Net Chg. in Cash-$464$641-$107-$202
Supplemental Information
Beg. Cash$1,720$1,079$1,185$1,387
End Cash$1,256$1,720$1,079$1,185
Free Cash Flow$549$621$17$591
Fresenius Medical Care AG & Co. KGaA (FMS) Financial Statements & Key Stats | AlphaPilot